Cowen Prime Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Cowen Prime Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,000	Closed	-$136K	–	183
2019 Q3	$136K	Hold	2,000	–	–	0.07%	78
2019 Q2	$116K	Hold	2,000	–	–	0.06%	91
2019 Q1	$140K	Hold	2,000	–	–	0.07%	75
2018 Q4	$129K	Hold	2,000	–	–	0.08%	80
2018 Q3	$140K	Sell	2,000 -400	-17%	-$23.4K	0.07%	96
2018 Q2	$121K	Hold	2,400	–	–	0.06%	97
2018 Q1	$75K	Sell	2,400 -108,198	-98%	-$3.59M	0.04%	126
2017 Q4	$3.78M	Sell	110,598 -14,266	-11%	-$455K	1.84%	17
2017 Q3	$4.01M	Buy	124,864 +36,229	+41%	+$1.14M	1.91%	16
2017 Q2	$2.88M	Buy	88,635 +67,735	+324%	+$2.15M	1.33%	23
2017 Q1	$658K	Buy	+20,900	New	+$618K	0.34%	50

Cowen Prime Advisors's GHDX Position: Q4 2019 in Review

Cowen Prime Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 2,000 shares — an estimated $136K sold.

Cowen Prime Advisors first reported a position in GHDX in Q1 2017 and held it in 11 quarters. The position peaked at $4.01M in Q3 2017. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Cowen Prime Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Cowen Prime Advisors sold 2,000 Genomic Health, Inc. shares in Q4 2019, an estimated $136K.
Cowen Prime Advisors first reported a position in Genomic Health, Inc. in Q1 2017 and held it in 11 quarters.
Cowen Prime Advisors's Genomic Health, Inc. position peaked at $4.01M in Q3 2017.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Cowen Prime Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.